CD24 Expression is an Independent Prognostic Marker in Cholangiocarcinoma

CD24 has been described as an adverse prognostic marker in several malignancies. This study evaluates CD24 expression in cholangiocarcinoma and correlates the findings with clinicopathologic data and patient survival. Between 1996 and 2002, 22 consecutive patients with cholangiocarcinoma were treate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Agrawal, Shefali, Kuvshinoff, Boris W., Khoury, Thaer, Yu, Jihnhee, Javle, Milind M., LeVea, Charles, Groth, Jeff, Coignet, Lionel J., Gibbs, John F.
Format: Artigo
Jezik:Inglês
Izdano: Springer-Verlag 2007
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC1852393/
https://ncbi.nlm.nih.gov/pubmed/17436128
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11605-007-0091-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki